1. W.H.O (2019) http://www.who.int/news-room/fact-sheets/detail/tuberculosis.
2. W.H.O (2021) https://www.who.int/health-topics/tuberculosis#tab=tab_1.
3. 2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease;Ajala;Futur. J. Pharm. Sci.,2022
4. Implementation of self-reporting pharmacovigilance in anti-tubercular therapy using knowledge based approach;Abideen;J. Pharmacovigil.,2013
5. Structure-based drug design of novel piperazine containing hydrazone derivatives as potent Alzheimer inhibitors: molecular docking and drug kinetics evaluation;Ajala;Brain Disorders,2022